Concepedia

Paula Soria‐Chacartegui

PS

Statistics

Publications

11

Citations

173

H-Index

10

Active since

2020

Affiliations

Universidad Autónoma de Madrid(Current)

Hospital Universitario de La Princesa

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Instituto de Salud Carlos III

Spanish Clinical Research Network

Paula Soria‐Chacartegui is an author at Universidad Autónoma de Madrid specializing in pharmacology, drug discovery, and pharmacokinetics.

ORCID

Top concepts

Publications per year

2020–2023

11

Publications

11

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

Pablo Zubiaur, Miriam Saiz‐Rodríguez, Dolores Ochoa et al. · Advances in Therapy · 2020 · 24 citations

, , +5

Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam

Pablo Zubiaur, Laura Figueiredo-Tor, Gonzalo Villapalos‐García et al. · Biomedicine & Pharmacotherapy · 2022 · 23 citations · Full text

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers

Pablo Zubiaur, Paula Soria‐Chacartegui, Dóra Koller et al. · Biomedicine & Pharmacotherapy · 2020 · 22 citations · Full text

Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers

Ana Casajús, Pablo Zubiaur, Marta Méndez et al. · Advances in Therapy · 2022 · 18 citations · Full text

Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics

Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares‐Gómez et al. · Pharmaceutics · 2021 · 15 citations · Full text

1–5 of 11